Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Private Investments to Boost Growth in Brazil Generics
Apr 15, 2010
The generics industry has strongly benefited from the soaring investments made in the sector in recent years. After generics were first approved in 2000, investment in the sector has seen strong growth, with both domestic and foreign players investing millions of dollars. As per a new research on the sector called “Brazil Generics Market Forecast to 2012” by RNCOS, the generic drugs market in Brazil is projected to grow at a CAGR of around 19% during 2010-2012.
We have done extensive research and prudent analysis of the generics market in Brazil in order to understand the factors that will continue to serve as growth propellers for the market over the coming years. We have identified that various other factors, such as patent expiries, government initiatives, aging population and increasing prescription rates have promoted the use of generic drugs in the country, thus leading the market to witness remarkable growth. The report also gives insight into the role of the country’s regulatory environment in the development of its generic drugs industry.
The report discusses the potential of generic drugs in various therapeutic segments in the pharma industry, which will give a clear idea about the type of products available in the market. Apart from this, the report also discusses several industry bottlenecks that are blocking the growth of generics industry in the country.
"Brazil Generics Market Forecast to 2012" provides an extensive research and conceptual study of the generic drugs market in Brazil. It also covers various growth-supporting factors like macroeconomic environment, market drivers and their impact and other factors supporting the industry growth. The report thoroughly examines the current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Industry forecasts presented in the research report has been made carefully after considering all the possible post-recession impacts on the industry.
For more information visit: http://www.rncos.com/Report/IM249.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
- Generic Cancer Drugs Made More Accessible to Developing Countries
- Strategic Collaborations for Developing Low Priced Cancer Generics
- Entry of Indian Cancer Generics in the US - Driving Global Market
- Entry of Indian Cancer Generics in the US - Driving Global Market
- Effective Regulations to Boost Generics in South Africa
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact